https://www.indianpharmapost.com/jb-pharma-posts-q2-fy25-pat-16-higher-at-rs-175-cr-163952024-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/vijaya-diagnostic-centre-posts-q2-fy25-pat-at-rs-4195-cr-164042024-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-pharmaceuticals-q2-fy25-pat-up-12-to-rs-153-cr-164032024-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/ichnos-glenmark-innovation-to-present-phase-1-study-of-trispecific-isb-2001-in-rrmm-at-ash-annual-meeting-164022024-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/apollo-hospitals-reports-q2-fy25-consolidated-pat-at-rs-3788-cr-164012024-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/max-healthcare-posts-q2-fy25-consolidated-pat-at-rs-28181-cr-164002024-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/mitsui-chemicals-invests-in-clinical-kidney-disease-drug-developer-rege-nephro-163992024-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/mitsui-chemicals-begins-sale-of-i-tfc-luminous-ii-dental-material-range-163982024-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/kims-to-acquire-3000-beds-in-next-5-years-in-kerala-163972024-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/kwality-pharma-received-approval-for-leuprorelin-acetate-for-injectable-suspension-from-greece-163962024-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/rpg-life-sciences-posts-q2-fy25-revenue-up-by-12-yoy-164052024-11-07T00:00:00+05:30always0.9